Correction to: Results of a randomized trial of treatment modalities in patients with low or early-intermediate risk prostate cancer (PREFERE trial)
J Cancer Res Clin Oncol
.
2021 Jan;147(1):243-244.
doi: 10.1007/s00432-020-03497-z.
Authors
Thomas Wiegel
1
,
Peter Albers
2
,
Detlef Bartkowiak
3
,
Roswitha Bussar-Maatz
4
,
Martin Härter
5
,
Glen Kristiansen
6
,
Peter Martus
7
,
Stefan Wellek
8
,
Heinz Schmidberger
9
,
Klaus Grozinger
10
,
Peter Renner
11
,
Fried Schneider
12
,
Martin Burmester
13
,
Michael Stöckle
14
Affiliations
1
Department of Radiotherapy and Radiation Oncology, University Hospital Ulm, Albert-Einstein-Allee 23, 89081, Ulm, Germany.
[email protected]
.
2
Department of Urology, University Hospital Düsseldorf, Düsseldorf, Germany.
3
Department of Radiotherapy and Radiation Oncology, University Hospital Ulm, Albert-Einstein-Allee 23, 89081, Ulm, Germany.
4
PREFERE Project Management, German Cancer Society, Berlin, Germany.
5
Department of Medical Psychology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
6
Institute of Pathology, University Hospital Bonn, Bonn, Germany.
7
Department of Clinical Epidemiology and Applied Biostatistics, University Hospital Tübingen, Tübingen, Germany.
8
Department of Medical Biostatistics, Epidemiology and Informatics, University of Mainz, Mainz, Germany.
9
Department of Radiotherapy and Radiation Oncology, University Hospital Mainz, Mainz, Germany.
10
Department of Urology, Klinikum Leverkusen, Leverkusen, Germany.
11
Center for Urology, Lübeck, Germany.
12
Department of Urology, Klinikum Lippe Detmold, Detmold, Germany.
13
Department of Urology, Vinzenzkrankenhaus, Hannover, Germany.
14
Department of Urology, University Hospital Homburg/Saar, Homburg, Germany.
PMID:
33346877
PMCID:
PMC7919773
DOI:
10.1007/s00432-020-03497-z
No abstract available
Publication types
Published Erratum